PKI News and Press, PerkinElmer Inc. From 07/21/22

Although the healthcare sector has largely resisted this year's downward pressure, it is likely to succumb as pressure increases. Healthcare stocks have a well-deserved reputation for cyclical defense, but they are more likely to underperform in "secular" bear markets. Healthcare ...

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will release its second quarter 2022 financial results on Thursday, August 4, 2022 at 6:00 a.m. ET. The Company will host a conference call the same day at ...

West Pharmaceutical Services has performed extraordinarily well in recent years. The future of the enterprise looks bright and the company will likely continue to fare well in the years to come. But given how pricey shares are today, buying it won't make sense to a lot of investor...

GC 2400 solution streamlines performance and delivers superior precision for high throughput environments PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today launched the GC 2400™ Platform , an advanced, auto...

U.S. outlays from the National Institutes of Health (NIH), clinical trials, and healthcare government grants for May increased over April and Y/Y, according to Baird Equity Research.  In May, NIH outlays increased ~13% YY in May  and 16% vs. April to $3.49B, after a 1...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Affordable, easy-to-use benchtop system empowers labs of all sizes to both generate and quality control NGS libraries for genomic analysis PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the launch of the rese...

Waters Corporation has followed the broader market lower, even as the company shows some attractive financial results. Long term, the picture for the business will likely be favorable, but this doesn't change the fact that there are more appealing opportunities to be had. This is ...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

PerkinElmer has experienced significant growth over the past few years, admittedly with some of it being temporary because of the pandemic. This year should be weaker than last year was, but the overall fundamental condition for the enterprise is solid. Add in that shares look att...